Analyst Ratings News 8 December 2025

Walmart Stock (WMT) After Nasdaq Debut: Price Action, Analyst Upgrades and What to Watch Before the December 10, 2025 Open

Key takeaways How Walmart stock traded on December 9, 2025 Price action and volume after the bell On Tuesday, December 9, 2025 — Walmart’s first session trading on the Nasdaq under ticker WMT — the stock added roughly 1.3%, trading

10 December 2025

Cisco Stock (CSCO) Tests $80 Resistance as AI Demand Surges: Latest News, Analyst Ratings and Price Forecasts – December 9, 2025

Cisco Systems, Inc. (NASDAQ: CSCO) remains firmly in the market spotlight on December 9, 2025, as its share price pushes up against the psychologically important $80 resistance level while Wall Street continues to re-rate the networking giant on the back

9 December 2025

AI Technology · Analyst Ratings · Cisco · NASDAQ:CSCO · Price Forecasts · Stock Market

Warner Bros. Discovery, Inc. – Series A (WBD) Stock on December 9, 2025: Netflix vs. Paramount Skydance Takeover War, Analyst Downgrades and Fresh Price Targets

Warner Bros. Discovery, Inc. – Series A (NASDAQ: WBD) has become the most dramatic story in global media and entertainment markets. On December 9, 2025, the stock is trading near takeover prices as Netflix and Paramount Skydance battle in public

9 December 2025

Analyst Ratings · Company Comparisons · Investment Strategies · Media Industry · Stock Market News

SLM Stock Plunges Over 16% After Investor Day: New EPS Targets, Analyst Downgrades and 2026–2028 Outlook for Sallie Mae (SLM)

SLM stock today: a brutal reaction to Investor Forum 2025 Sallie Mae parent SLM Corporation (NASDAQ: SLM) is getting hammered on 9 December 2025 after its 2025 Investor Forum triggered an “earnings reset” narrative on Wall Street. By early U.S.

9 December 2025

Analyst Ratings · Earnings Reports · Financial News · Market Outlook · NASDAQ:SLM · Stocks

Inspire Medical Systems (INSP) Stock on December 9, 2025: Rebound Rally Meets Legal Overhang and Mixed Analyst Targets

Inspire Medical Systems, Inc. (NYSE: INSP), a leading developer of implantable devices to treat obstructive sleep apnea, is back in the spotlight. As of December 9, 2025, the stock is trading near the upper end of its recent rebound, supported

9 December 2025

Analyst Ratings · Healthcare Stocks · Investment Analysis · Legal News · NYSE:INSP · Stock Market

Kontoor Brands (KTB) Stock on December 9, 2025: Q3 Beat, Analyst Upgrades and Volatile Trading Create a 2026 Upside Story

As of December 9, 2025, Kontoor Brands, Inc. (NYSE: KTB) — the parent company behind Wrangler, Lee and Helly Hansen — sits in an interesting sweet spot: strong fundamentals, bullish analyst targets, but a share price that’s been knocked around

9 December 2025

Analyst Ratings · Earnings Reports · Investment Strategies · Market Trends · NYSE:KTB · Stock Market

Arcellx (ACLX) Stock Surges on Anito-cel Breakthrough Data as Analysts Boost Price Targets – December 9, 2025

Published: December 9, 2025 Arcellx, Inc. (NASDAQ: ACLX) has jumped back onto Wall Street’s radar after releasing highly positive Phase 2 data for its multiple myeloma cell therapy anitocabtagene autoleucel (“anito-cel”) at the American Society of Hematology (ASH) 2025 meeting.

9 December 2025

Analyst Ratings · Biotechnology · Financial Updates · Investment News · NASDAQ:ACLX · Stock Market

Magnum Ice Cream Company N.V. (MICC) Stock: Fresh Analyst Ratings, Outlook and Risks After the Unilever Demerger – 9 December 2025

December 9, 2025 The Magnum Ice Cream Company N.V. (ticker: MICC) is barely into its first full week as an independently listed company, and the market is already trying to figure out what this €7.8–7.9 billion ice cream giant is

9 December 2025

Analyst Ratings · Company News · Financial Risk · Investment Insights · NYSE:MICC · Stock Market

Eaton Stock (ETN) on December 9, 2025: Wolfe Upgrade, AI Data Center Bets and What It Means for Investors

Eaton Corporation plc (NYSE: ETN) is back in the spotlight on December 9, 2025, as Wall Street leans more bullish on the stock despite a recent pullback and rich valuation multiples. After weeks of drifting lower from its summer highs,

9 December 2025

Analyst Ratings · Artificial Intelligence · Data Centers · Investing · Stock Market

Salesforce (CRM) After-Hours Update for December 8, 2025: AI Momentum, Citigroup Downgrade and What to Watch Before the December 9 Open

Salesforce, Inc. (NYSE: CRM) slipped modestly on Monday, December 8, 2025, as a week-long AI-fueled rally cooled and Wall Street digested a fresh downgrade from Citigroup alongside a flurry of new “agentic AI” announcements from the company. The stock closed

9 December 2025

AI Trends · Analyst Ratings · Investment Strategies · NYSE:CRM · Stock Market · Technology

Gilead Sciences (GILD) Stock Today: Price, Fresh News and Analyst Outlook on December 8, 2025

As of Monday, December 8, 2025, Gilead Sciences, Inc. (NASDAQ: GILD) sits near the upper end of its 52‑week range, supported by strong HIV franchises, new long‑acting prevention drugs, high‑profile cancer data at ASH 2025 and a steady dividend. At

8 December 2025

Analyst Ratings · Biotech · Market Analysis · NASDAQ:GILD · Pharmaceutical Stocks · Stock News

MercadoLibre (MELI) Stock Today: December 8, 2025 Update on Price, Q3 Results, Bond Deal and Analyst Forecasts

As of Monday, December 8, 2025, MercadoLibre, Inc. (NASDAQ: MELI) remains one of the most closely watched growth stocks in emerging markets. The Latin American e‑commerce and fintech leader is trading a little above $2,080 per share, giving it a

8 December 2025

Analyst Ratings · Earnings Reports · Financial News · Investing · Stock Market

Analyst Ratings News 8 December 2025 - 10 December 2025